The services will support the institute's precision medicine programs such as Genomic Answers for Kids.

In a Phase II trial, 47 percent of patients on the immunotherapy had a complete response lasting at least 12 months.

NEW YORK – Danaher on Wednesday reported a 9 percent year-over-year third quarter revenue increase, prompting the firm to increase its full-year earnings per share guidance.

NEW YORK – OncoC4 said this week the China National Medical Products Administration (NMPA) has accepted two investigational new drug applications seeking to test its PD-1/VEGF bispecific antibody ...

NEW YORK – A proposal by the US Centers for Medicare and Medicaid Services (CMS) to loosen the qualifications required of directors of high-complexity clinical laboratories has drawn opposition from ...

NEW YORK – Waters and Quest Diagnostics announced on Tuesday a collaboration to expand access to at-home cervical cancer screening using the Waters’ Onclarity Self-Collection Kit and extended human ...

NEW YORK — Takara Bio USA and SPT Labtech said on Tuesday that they have agreed to develop automated sample preparation workflows that combine their respective technologies.

The German pharma giant will acquire the siRNA drug developer in an all-cash transaction to support its work in targeted specialty and rare diseases.

NEW YORK – Investigators in France and the US have identified multiomic features in newly diagnosed multiple myeloma cases that differ between those with or without measurable residual disease (MRD) ...

NEW YORK – According to revenue cycle management firm Xifin’s recently released 2026 Payor Denial Impact Report, the denial rate for clinical lab services was 11.2 percent in 2025, up 40 percent from ...

NEW YORK – The California Institute for Regenerative Medicine (CIRM) has awarded Epicrispr Biotechnologies an $8 million grant to support the development of its lead candidate for facioscapulohumeral ...